Clinical Trial Update: A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection [Phase 2]

View source ↗

Summary

This item reports a Phase II clinical trial evaluating a reduced-port totally laparoscopic distal gastrectomy with D2 lymph node dissection for gastric cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN